2018
Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy
Butalia S, Audibert F, Côté AM, Firoz T, Logan AG, Magee LA, Mundle W, Rey E, Rabi DM, Daskalopoulou SS, Nerenberg KA, Canada H. Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy. Canadian Journal Of Cardiology 2018, 34: 526-531. PMID: 29731014, DOI: 10.1016/j.cjca.2018.02.021.Peer-Reviewed Original ResearchConceptsManagement of hypertensionAntihypertensive therapySevere hypertensionBlood pressure targetsNewborn adverse outcomesManagement of womenTreatment of hypertensionGynaecologists of CanadaSociety of ObstetriciansAntihypertensive medicationsNonsevere hypertensionPressure targetsNewborn complicationsAdverse outcomesCanadian recommendationsHypertensionPregnancyCanada guidelinesTherapyGuidelinesSpecific evidenceManagementMedicationsComplicationsObstetriciansHypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children
Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Padwal RS, Tran KC, Grover S, Rabkin SW, Moe GW, Howlett JG, Lindsay P, Hill MD, Sharma M, Field T, Wein TH, Shoamanesh A, Dresser GK, Hamet P, Herman RJ, Burgess E, Gryn SE, Grégoire JC, Lewanczuk R, Poirier L, Campbell TS, Feldman RD, Lavoie KL, Tsuyuki RT, Honos G, Prebtani APH, Kline G, Schiffrin EL, Don-Wauchope A, Tobe SW, Gilbert RE, Leiter LA, Jones C, Woo V, Hegele RA, Selby P, Pipe A, McFarlane PA, Oh P, Gupta M, Bacon SL, Kaczorowski J, Trudeau L, Campbell NRC, Hiremath S, Roerecke M, Arcand J, Ruzicka M, Prasad GVR, Vallée M, Edwards C, Sivapalan P, Penner SB, Fournier A, Benoit G, Feber J, Dionne J, Magee LA, Logan AG, Côté AM, Rey E, Firoz T, Kuyper LM, Gabor JY, Townsend RR, Rabi DM, Daskalopoulou SS, Canada H. Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Canadian Journal Of Cardiology 2018, 34: 506-525. PMID: 29731013, DOI: 10.1016/j.cjca.2018.02.022.Peer-Reviewed Original ResearchConceptsBlood pressure monitoringTreatment of hypertensionBlood pressurePressure monitoringGuideline-directed heart failure therapyAmbulatory blood pressure monitoringHome blood pressure monitoringAngiotensin-converting enzyme inhibitorGlobal cardiovascular riskLarge arm circumferenceSetting of thrombolysisAngiotensin receptor blockersAcute ischemic strokeWhite-coat effectHeart failure therapyLower blood pressureUpper arm deviceEvidence-based guidelinesHypertension CanadaHypertension guidelinesReceptor blockersCardiovascular riskFailure therapyIschemic strokeHeart failure
2014
Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review
Firoz T, Magee L, MacDonell K, Payne B, Gordon R, Vidler M, von Dadelszen P, Group T. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. BJOG An International Journal Of Obstetrics & Gynaecology 2014, 121: 1210-1218. PMID: 24832366, PMCID: PMC4282072, DOI: 10.1111/1471-0528.12737.Peer-Reviewed Original ResearchConceptsOral antihypertensive agentsSevere hypertensionAntihypertensive agentsRelative riskOral antihypertensive therapySublingual nifedipine capsulesBlood pressure reductionRisk of strokePregnancy/postpartumResource-constrained settingsAntihypertensive therapyExperienced hypotensionOral labetalolOral nifedipineParenteral hydralazineFetal outcomesOral agentsPostpartum hypertensionDiastolic BPSystolic BPDATA COLLECTIONNifedipine capsulesTarget BPCochrane LibraryPostpartum women
2013
Pharmacotherapy for Preeclampsia in Low and Middle Income Countries: An Analysis of Essential Medicines Lists
Lalani S, Firoz T, Magee LA, Sawchuck D, Payne B, Gordon R, Vidler M, von Dadelszen P. Pharmacotherapy for Preeclampsia in Low and Middle Income Countries: An Analysis of Essential Medicines Lists. Journal Of Obstetrics And Gynaecology Canada 2013, 35: 215-223. PMID: 23470109, DOI: 10.1016/s1701-2163(15)30993-2.Peer-Reviewed Original ResearchConceptsEssential Medicines ListAntihypertensive therapyMiddle-income countriesMedicines ListOral antihypertensive therapyParenteral antihypertensive therapyNational essential medicines listsEclampsia/preeclampsiaPrevalence of drugIncome countriesWorld Health OrganizationOral furosemidePreeclampsia complicationsLabor inductionPreterm birthPulmonary edemaParenteral dexamethasoneSodium nitroprussideCalcium gluconatePreeclampsiaTherapyHealth OrganizationMagnesium sulfateComprehensive managementPharmacotherapy
2011
Postpartum evaluation and long term implications
Firoz T, Melnik T. Postpartum evaluation and long term implications. Best Practice & Research Clinical Obstetrics & Gynaecology 2011, 25: 549-561. PMID: 21536498, DOI: 10.1016/j.bpobgyn.2011.03.003.Peer-Reviewed Original ResearchConceptsCardiovascular diseaseEarly-onset pre-eclampsiaPre-existing metabolic abnormalitiesTraditional cardiovascular risk factorsCardiovascular risk factorsPremature cardiovascular diseaseIschemic heart diseaseManagement of hypertensionHeart-healthy lifestyleLong-term implicationsPostpartum evaluationRenal diseaseMetabolic abnormalitiesPre-eclampsiaNext pregnancyWeeks postpartumHeart diseaseMonths postpartumPostpartum periodRisk factorsSecondary causesHigh riskHypertensionCare needsDisease pathophysiology